EYESW (Second Sight Medical Products) EPS (Diluted) : $0.00 (TTM As of Jun. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Second Sight Medical Products EPS (Diluted)?

Second Sight Medical Products's Earnings per Share (Diluted) for the three months ended in Jun. 2022 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00.

Second Sight Medical Products's EPS (Basic) for the three months ended in Jun. 2022 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00.

Second Sight Medical Products's EPS without NRI for the three months ended in Jun. 2022 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 80.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 49.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Second Sight Medical Products's highest 3-Year average EPS without NRI Growth Rate was 80.00% per year. The lowest was -96.20% per year. And the median was 27.80% per year.

Second Sight Medical Products EPS (Diluted) Historical Data

The historical data trend for Second Sight Medical Products's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products EPS (Diluted) Chart

Second Sight Medical Products Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EPS (Diluted)

Get a 7-Day Free Trial

Second Sight Medical Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
EPS (Diluted)	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Second Sight Medical Products's EPS (Diluted)

For the Medical Devices subindustry, Second Sight Medical Products's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Second Sight Medical Products's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's PE Ratio distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's PE Ratio falls into.

Save Embed

;

Save Embed

;

Second Sight Medical Products EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Second Sight Medical Products's Diluted EPS for the fiscal year that ended in Dec. 2021 is calculated as

Diluted EPS (A: Dec. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-8.921	-	0)	/	0
	=

Second Sight Medical Products's Diluted EPS for the quarter that ended in Jun. 2022 is calculated as

Diluted EPS (Q: Jun. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-3.076	-	0)	/	0
	=

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Second Sight Medical Products (NAS:EYESW) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Second Sight Medical Products EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Second Sight Medical Products Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYESW) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

13170 Telfair Avenue, Sylmar, CA, USA, 91342

Website

https://www.secondsight.com

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.